1. Gilead’s Kite files for FDA approval of second CAR-T — Merck’s Keytruda gets win for triple-negative breast cancer — The House votes on the Lower Drug Cost Now Act — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Neurovascular

Discussion in 'Stryker' started by anonymous, Oct 28, 2019 at 3:08 PM.

  1. anonymous

    anonymous Guest

    what's the scoop over here?
     
  2. anonymous

    anonymous Guest

    I am quite curious about this as well. Recruiters are saying it's near impossible to get hired on as a full rep even with 10 years of OR Capital and procedural experience. Is this accurate?
     
  3. anonymous

    anonymous Guest

    If you don't pass the Gallup, yes.